부산대학교 도서관

Shankar-Hari, M; Vale, CL; Godolphin, PJ; Fisher, D; Higgins, JPT; Spiga, F; Savovic, J; Tierney, J; Baron, G; Benbenishty, JS; Berry, LR; Broman, N; Cavalcanti, AB; Colman, R; De Buyser, SL; Derde, LPG; Domingo, P; Omar, SF; Fernandez-Cruz, A; Feuth, T; Garcia, F; Garcia-Vicuna, R; Gonzalez-Alvaro, I; Gordon, AC; Haynes, R; Hermine, O; Horby, PW; Horick, NK; Kumar, K; Lambrecht, BN; Landray, MJ; Leal, L; Lederer, DJ; Lorenzi, E; Mariette, X; Merchante, N; Misnan, NA; Mohan, S; Nivens, MC; Oksi, J; Perez-Molina, JA; Pizov, R; Porcher, R; Postma, S; Rajasuriar, R; Ramanan, A; Ravaud, P; Reid, PD; Rutgers, A; Sancho-Lopez, A; Seto, TB; Sivapalasingam, S; Soin, AS; Staplin, N; Stone, JH; Strohbehn, GW; Sunden-Cullberg, J; Torre-Cisneros, J; Tsai, LW; van Hoogstraten, H; van Meerten, T; Veiga, VC; Westerweel, PE; Murthy, S; Diaz, J; Marshall, JC; Sterne, JAC

JAMA. 326(6):499-518

Sears, Stephen T.; Niven, Alex

Military Medicine. Spring2004 Supplement, p7-8. 2p.

Rabe KF; LungenClinic Grosshansdorf, Airway Research Center North, Grosshansdorf, Germany.; Christian-Albrechts University of Kiel, Airway Research Center North, Kiel, Germany.; German Center for Lung Research, Grosshansdorf, Germany.; Martinez FJ; Weill Cornell Medical College, New York, NY, USA.; Bhatt SP; University of Alabama at Birmingham, Birmingham, AL, USA.; Kawayama T; Kurume University School of Medicine, Fukuoka, Japan.; Cosio BG; Hospital Universitario Son Espases-IdISBa-CIBERES, Palma de Mallorca, Spain.; Mroz RM; Medical University of Bialystok, Bialystok, Poland.; Boomsma MM; Sanofi, Amsterdam, Netherlands.; Goulaouic H; Sanofi, Chilly-Mazarin, France.; Nivens MC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Djandji M; Sanofi, Cambridge, MA, USA.; Soler X; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Liu Y; Sanofi, Bridgewater, NJ, USA.; Kosloski MP; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Xu CR; Sanofi, Bridgewater, NJ, USA.; Amin N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Staudinger H; Sanofi, Bridgewater, NJ, USA.; Lederer DJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Abdulai RM; Former Sanofi employee.

Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE

Xu C; Sanofi, Bridgewater, NJ, USA.; Xin K; Sanofi, Beijing, China.; Kosloski MP; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA.; Butler A; Sanofi, Bridgewater, NJ, USA.; Goulaouic H; Sanofi, Chilly-Mazarin, France.; Nivens MC; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA.; Kanamaluru V; Sanofi, Bridgewater, NJ, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

Kosloski MP; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.; Guttman-Yassky E; Icahn School of Medicine at Mount Sinai Medical Center, New York, New York, USA.; Rockefeller University, New York, New York, USA.; Cork MJ; Sheffield Dermatology Research, University of Sheffield, Sheffield, UK.; Sheffield Children's Hospital, Sheffield, UK.; Worm M; Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Nahm DH; Ajou University Hospital, Suwon, Korea.; Zhu X; Formerly Regeneron Pharmaceuticals Inc., Basking Ridge, New Jersy, USA.; Ruddy MK; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.; Harel S; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.; Kamal MA; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.; Goulaouic H; Sanofi, Chilly-Mazarin, France.; Xu CR; Sanofi, Bridgewater, New Jersey, USA.; Avetisova E; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.; Davis JD; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.; Nivens MC; Formerly Regeneron Pharmaceuticals, Tarrytown, New York, USA.; Shabbir A; Formerly Regeneron Pharmaceuticals, Tarrytown, New York, USA.; Radin A; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.

Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

Yosipovitch G; Dr Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami, Miami, Florida.; Kim BS; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.; Kwatra SG; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Mollanazar NK; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.; Ständer S; Department of Dermatology and Center for Chronic Pruritus, University Hospital Münster, Mϋnster, Germany.; Satoh T; Department of Dermatology, National Defense Medical College, Tokorozawa, Japan.; Mendes-Bastos P; Dermatology Center, Hospital CUF Descobertas, Lisbon, Portugal.; Tsai TF; Department of Dermatology, National Taiwan University Hospital, Taipei City, Taiwan.; Laws E; Sanofi, Bridgewater, New Jersey.; Nivens MC; Regeneron Pharmaceuticals Inc, Tarrytown, New York.; Maloney J; Regeneron Pharmaceuticals Inc, Tarrytown, New York.; Shi G; Sanofi, Bridgewater, New Jersey.; Bansal A; Regeneron Pharmaceuticals Inc, Tarrytown, New York.; Dubost-Brama A; Sanofi, Gentilly, France.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774762 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3287 (Electronic) Linking ISSN: 26663287 NLM ISO Abbreviation: JAAD Int Subsets: PubMed not MEDLINE

Faiz, A; Mahbub, RM; Boedijono, FS; Tomassen, MI; Kooistra, W; Timens, W; Nawijn, M; Hansbro, PM; Johansen, MD; Pouwels, SD; Heijink, IH; Massip, F; de Biase, MS; Schwarz, RF; Adcock, IM; Chung, KF; van der Does, A; Hiemstra, PS; Goulaouic, H; Xing, H; Abdulai, R; de Rinaldis, E; Cunoosamy, D; Harel, S; Lederer, D; Nivens, MC; Wark, PA; Kerstjens, HAM; Hylkema, MN; Brandsma, C-A; van den Berge, M; Cambridge Lung Cancer Early Detection Programme

Spiera RF; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Unizony S; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Warrington KJ; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Sloane J; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Giannelou A; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Nivens MC; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Akinlade B; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Wong W; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Bhore R; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Lin Y; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Buttgereit F; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Devauchelle-Pensec V; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Rubbert-Roth A; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Yancopoulos GD; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Marrache F; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Patel N; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).; Dasgupta B; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Doyle, Keith B.; Chalifoux, Brandon D.; Castle, Kenneth R.; Sasián, José M.; Tangari Larrategui, Martin; Camacho, Bianka; Tulungen, Paul; Baker, Christian; Densmore, Victor E.; Johnson, Lee; Hamilton, R. J.; Medicus, Kate; Castle, Kenneth R.; Stuhlinger, Tilman W.; Mc. Niven, Peter

Proceedings of SPIE; September 2023, Vol. 12669 Issue: 1 p126690G-126690G-11, 12542322p

Faiz A; Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.; Groningen Research Institute for Asthma and COPD.; Department of Pulmonary Diseases, and.; Mahbub RM; Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.; Boedijono FS; Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.; Centre for Inflammation, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, New South Wales, Australia.; Tomassen MI; Groningen Research Institute for Asthma and COPD.; Department of Pathology & Medical Biology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.; Kooistra W; Groningen Research Institute for Asthma and COPD.; Department of Pathology & Medical Biology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.; Timens W; Groningen Research Institute for Asthma and COPD.; Department of Pathology & Medical Biology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.; Nawijn M; Groningen Research Institute for Asthma and COPD.; Department of Pathology & Medical Biology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.; Hansbro PM; Centre for Inflammation, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, New South Wales, Australia.; Johansen MD; Centre for Inflammation, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, New South Wales, Australia.; Pouwels SD; Groningen Research Institute for Asthma and COPD.; Department of Pulmonary Diseases, and.; Heijink IH; Groningen Research Institute for Asthma and COPD.; Department of Pulmonary Diseases, and.; Department of Pathology & Medical Biology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.; Massip F; Centre for Computational Biology, Mines ParisTech, Paris Sciences et Lettres Research University, Paris, France.; Cancer and Genome: Bioinformatics, Biostatistics and Epidemiology of Complex Systems Institut Curie, Paris, France.; Institut Nationale de la Santé et de la Recherche Médicale U900, Paris, France.; de Biase MS; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Schwarz RF; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Institute for Computational Cancer Biology, Center for Integrated Oncology, Cancer Research Center Cologne Essen, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.; Berlin Institute for the Foundations of Learning and Data, Berlin, Germany.; Adcock IM; National Heart & Lung Institute, Imperial College London, London, United Kingdom.; Chung KF; National Heart & Lung Institute, Imperial College London, London, United Kingdom.; van der Does A; Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.; Hiemstra PS; Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.; Goulaouic H; Sanofi, Chilly-Mazarin, France.; Xing H; Sanofi, Chilly-Mazarin, France.; Abdulai R; Sanofi, Cambridge, Massachusetts.; de Rinaldis E; Sanofi, Cambridge, Massachusetts.; Cunoosamy D; Sanofi, Cambridge, Massachusetts.; Harel S; Regeneron Pharmaceuticals, Tarrytown, New York.; Lederer D; Regeneron Pharmaceuticals, Tarrytown, New York.; Nivens MC; Regeneron Pharmaceuticals, Tarrytown, New York.; Wark PA; Centre for Asthma & Respiratory Disease, The University of Newcastle, Newcastle, New South Wales, Australia; and.; Hunter Medical Research Institute, Vaccines, Infection, Viruses & Asthma Newcastle, New South Wales, Australia.; Kerstjens HAM; Groningen Research Institute for Asthma and COPD.; Department of Pulmonary Diseases, and.; Hylkema MN; Groningen Research Institute for Asthma and COPD.; Department of Pathology & Medical Biology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.; Brandsma CA; Groningen Research Institute for Asthma and COPD.; Department of Pathology & Medical Biology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.; van den Berge M; Groningen Research Institute for Asthma and COPD.; Department of Pulmonary Diseases, and.

Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE